Jane Street’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.26M | Sell |
6,429
-286,305
| -98% | -$55.6M | ﹤0.01% | 6017 |
|
|
2025
Q4 | $50.8M | Buy |
292,734
+219,577
| +300% | +$40M | 0.01% | 935 |
|
|
2025
Q3 | $13.9M | Buy |
73,157
+65,346
| +837% | +$11.6M | ﹤0.01% | 2020 |
|
|
2025
Q2 | $1.4M | Sell |
7,811
-78,083
| -91% | -$13.6M | ﹤0.01% | 5002 |
|
|
2025
Q1 | $14.5M | Buy |
85,894
+67,020
| +355% | +$11M | ﹤0.01% | 1570 |
|
|
2024
Q4 | $2.85M | Sell |
18,874
-35,866
| -66% | -$5.58M | ﹤0.01% | 3540 |
|
|
2024
Q3 | $8.5M | Sell |
54,740
-136,015
| -71% | -$20.3M | ﹤0.01% | 2101 |
|
|
2024
Q2 | $26.1M | Buy |
190,755
+160,101
| +522% | +$21.9M | 0.01% | 1097 |
|
|
2024
Q1 | $4.08M | Sell |
30,654
-19,756
| -39% | -$2.56M | ﹤0.01% | 2937 |
|
|
2023
Q4 | $6.95M | Sell |
50,410
-7,212
| -13% | -$948K | ﹤0.01% | 2399 |
|
|
2023
Q3 | $7.02M | Sell |
57,622
-17,315
| -23% | -$2.31M | ﹤0.01% | 2183 |
|
|
2023
Q2 | $10.5M | Buy |
74,937
+22,527
| +43% | +$3.11M | ﹤0.01% | 1846 |
|
|
2023
Q1 | $7.41M | Buy |
52,410
+28,423
| +118% | +$4.07M | ﹤0.01% | 1945 |
|
|
2022
Q4 | $3.75M | Sell |
23,987
-31,934
| -57% | -$4.59M | ﹤0.01% | 2885 |
|
|
2022
Q3 | $6.86M | Buy |
55,921
+941
| +2% | +$124K | ﹤0.01% | 2158 |
|
|
2022
Q2 | $7.31M | Buy |
54,980
+597
| +1% | +$81.3K | ﹤0.01% | 2131 |
|
|
2022
Q1 | $7.44M | Buy |
54,383
+50,107
| +1,172% | +$6.98M | ﹤0.01% | 2404 |
|
|
2021
Q4 | $740K | Sell |
4,276
-76,861
| -95% | -$11.7M | ﹤0.01% | 6525 |
|
|
2021
Q3 | $11.8M | Buy |
81,137
+9,971
| +14% | +$1.46M | ﹤0.01% | 1599 |
|
|
2021
Q2 | $9.39M | Buy |
71,166
+40,972
| +136% | +$5.36M | ﹤0.01% | 1794 |
|
|
2021
Q1 | $3.88M | Sell |
30,194
-59,449
| -66% | -$7.33M | ﹤0.01% | 2804 |
|
|
2020
Q4 | $10.7M | Buy |
89,643
+42,522
| +90% | +$5.18M | 0.01% | 1359 |
|
|
2020
Q3 | $5.39M | Sell |
47,121
-7,620
| -14% | -$900K | ﹤0.01% | 1776 |
|
|
2020
Q2 | $6.24M | Buy |
54,741
+27,424
| +100% | +$2.91M | ﹤0.01% | 1603 |
|
|
2020
Q1 | $2.19M | Buy |
+27,317
| New | +$2.83M | ﹤0.01% | 1932 |
|
|
2019
Q4 | – | Sell |
-5,661
| Closed | -$590K | – | 5155 |
|
|
2019
Q3 | $606K | Buy |
5,661
+3,217
| +132% | +$330K | ﹤0.01% | 3300 |
|
|
2019
Q2 | $249K | Sell |
2,444
-7,022
| -74% | -$675K | ﹤0.01% | 4436 |
|
|
2019
Q1 | $851K | Buy |
+9,466
| New | +$820K | ﹤0.01% | 3015 |
|
|
2018
Q3 | – | Sell |
-15,876
| Closed | -$1.75M | – | 5189 |
|
|
2018
Q2 | $1.75M | Buy |
+15,876
| New | +$1.65M | ﹤0.01% | 2098 |
|
|
2017
Q4 | – | Sell |
-47,932
| Closed | -$4.49M | – | 4659 |
|
|
2017
Q3 | $4.49M | Buy |
47,932
+44,588
| +1,333% | +$4.73M | 0.01% | 943 |
|
|
2017
Q2 | $371K | Sell |
3,344
-15,691
| -82% | -$1.66M | ﹤0.01% | 3372 |
|
|
2017
Q1 | $1.87M | Sell |
19,035
-3,049
| -14% | -$291K | 0.01% | 1433 |
|
|
2016
Q4 | $2.03M | Buy |
22,084
+9,218
| +72% | +$794K | 0.01% | 1315 |
|
|
2016
Q3 | $1.09M | Buy |
12,866
+4,071
| +46% | +$342K | 0.01% | 1846 |
|
|
2016
Q2 | $716K | Buy |
+8,795
| New | +$670K | ﹤0.01% | 2369 |
|
|
2015
Q4 | – | Sell |
-8,321
| Closed | -$559K | – | 4059 |
|
|
2015
Q3 | $511K | Buy |
+8,321
| New | +$582K | ﹤0.01% | 2279 |
|
|
2015
Q2 | – | Sell |
-8,210
| Closed | -$606K | – | 3690 |
|
|
2015
Q1 | $631K | Buy |
+8,210
| New | +$588K | ﹤0.01% | 1812 |
|
|
2014
Q1 | – | Sell |
-4,726
| Closed | -$253K | – | 2730 |
|
|
2013
Q4 | $253K | Sell |
4,726
-5,539
| -54% | -$329K | ﹤0.01% | 1805 |
|
|
2013
Q3 | $634K | Buy |
+10,265
| New | +$614K | 0.01% | 1534 |
|
Other funds holding DGX
VCM
VPM
EIG
Jane Street's DGX Position: Q1 2026 in Review
Jane Street reduced its Quest Diagnostics (DGX) stake by 98% in Q1 2026, selling an estimated $55.6M and leaving 6,429 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #6017.
Jane Street first reported a position in DGX in Q3 2013 and has held it in 39 quarters since. The position peaked at $50.8M in Q4 2025. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Jane Street held 6,429 shares of Quest Diagnostics worth $1.26M as of Q1 2026.
- Jane Street sold 286,305 Quest Diagnostics shares in Q1 2026, an estimated $55.6M.
- Quest Diagnostics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6017 holding.
- Jane Street first reported a position in Quest Diagnostics in Q3 2013 and has held it in 39 quarters since.
- Jane Street's Quest Diagnostics position peaked at $50.8M in Q4 2025.
- 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.